The researchers are doing this study to compare how music therapy and cognitive behavioral therapy, given virtually, may be able to reduce anxiety in people who have had cancer. In addition, this study will see if certain factors affect how well participants respond to music therapy or cognitive behavioral therapy. For example, the researchers will see if personal characteristics (like age, sex, race, and education) and ways of thinking (like expectations of therapy) may affect how well participants respond.
English- or Spanish-speaking
18 years or older
Prior cancer diagnosis of any type or stage
Free of oncological disease, or stable disease with no evidence of progression
Completed active cancer treatment (e.g., surgery, radiation, chemotherapy) less than one month prior to enrollment (maintenance hormonal or targeted therapies are allowed).
Active suicidal ideation, bipolar disorder, schizophrenia, or substance abuse
Score of ≥10 indicative of cognitive impairment on the Blessed Orientation-Memory-Concentration
Received a treatment course of seven or greater MT or CBT sessions for anxiety symptoms within the last six months
Parallel
Music Therapy
Other interventionParticipants will receive seven weekly 60-minute treatments of music therapy. All sessions will be delivered virtually through Zoom.
Cognitive Behavioral Therapy
Other interventionParticipants will receive seven weekly 60-minute treatment of cognitive behavioral therapy. All sessions will be delivered virtually through Zoom.
assessments
Other interventionParticipants will complete study assessments prior to randomization (week 0) and at weeks 4, 8, 16, and 26. A subgroup of 60 survivors will complete optional semi-structured interviews after treatment to understand their unique experiences with MT or CBT. All participants will be followed for 26 weeks.
HADS anxiety score changes
Using the seven-item anxiety sub-scale of the Hospital Anxiety and Depression Scale (HADS). A score of ≥8 indicates presence of anxiety symptoms.
HADS anxiety score changes
Using the seven-item anxiety sub-scale of the Hospital Anxiety and Depression Scale (HADS). A score of ≥8 indicates presence of anxiety symptoms.
Click on the lead sponsor to view all of their trials.
Memorial Sloan Kettering Cancer Center
Lead sponsor
Patient-Centered Outcomes Research Institute
Collaborator
